| 1 | Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells | 16.4 | 20 | Citations (PDF) |
| 2 | High-resolution CTCF footprinting reveals impact of chromatin state on cohesin extrusion | 13.7 | 5 | Citations (PDF) |
| 3 | Genetic predisposition to neuroblastoma results from a regulatory polymorphism that promotes the adrenergic cell state | 10.6 | 11 | Citations (PDF) |
| 4 | Enhancing CRISPR prime editing by reducing misfolded pegRNA interactions | 1.6 | 11 | Citations (PDF) |
| 5 | CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation | 5.5 | 43 | Citations (PDF) |
| 6 | Genome-wide functional perturbation of human microsatellite repeats using engineered zinc finger transcription factors | 6.8 | 9 | Citations (PDF) |
| 7 | Engineered CRISPR prime editors with compact, untethered reverse transcriptases | 29.8 | 81 | Citations (PDF) |
| 8 | A Code of Ethics for Gene Drive Research | 3.5 | 38 | Citations (PDF) |
| 9 | PrimeDesign software for rapid and simplified design of prime editing guide RNAs | 13.7 | 165 | Citations (PDF) |
| 10 | Scalable characterization of the PAM requirements of CRISPR–Cas enzymes using HT-PAMDA | 14.4 | 46 | Citations (PDF) |
| 11 | Analysis of off-target effects in CRISPR-based gene drives in the human malaria mosquito | 7.5 | 34 | Citations (PDF) |
| 12 | CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells | 29.8 | 189 | Citations (PDF) |
| 13 | Augmenting and directing long-range CRISPR-mediated activation in human cells | 24.6 | 29 | Citations (PDF) |
| 14 | Defining genome-wide CRISPR–Cas genome-editing nuclease activity with GUIDE-seq | 14.4 | 76 | Citations (PDF) |
| 15 | Zebrafish<i>dscaml1</i>Deficiency Impairs Retinal Patterning and Oculomotor Function | 3.7 | 25 | Citations (PDF) |
| 16 | Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources 2020, 8, e000990 | | 25 | Citations (PDF) |
| 17 | Mutant Allele-Specific CRISPR Disruption in DYT1 Dystonia Fibroblasts Restores Cell Function | 5.5 | 13 | Citations (PDF) |
| 18 | A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing | 29.8 | 228 | Citations (PDF) |
| 19 | Therapeutic base editing of human hematopoietic stem cells | 33.0 | 269 | Citations (PDF) |
| 20 | Disruption of the kringle 1 domain of prothrombin leads to late onset mortality in zebrafish | 3.4 | 20 | Citations (PDF) |
| 21 | Technologies and Computational Analysis Strategies for CRISPR Applications | 13.3 | 41 | Citations (PDF) |
| 22 | Optimization of AsCas12a for combinatorial genetic screens in human cells | 29.8 | 199 | Citations (PDF) |
| 23 | CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells | 29.8 | 498 | Citations (PDF) |
| 24 | Activities and specificities of <scp>CRISPR</scp>/Cas9 and Cas12a nucleases for targeted mutagenesis in maize | 8.8 | 237 | Citations (PDF) |
| 25 | Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss | 33.0 | 186 | Citations (PDF) |
| 26 | CRISPR DNA base editors with reduced RNA off-target and self-editing activities | 29.8 | 312 | Citations (PDF) |
| 27 | High levels of AAV vector integration into CRISPR-induced DNA breaks | 13.7 | 386 | Citations (PDF) |
| 28 | Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors | 37.9 | 582 | Citations (PDF) |
| 29 | Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing | 29.8 | 634 | Citations (PDF) |
| 30 | CRISPResso2 provides accurate and rapid genome editing sequence analysis | 29.8 | 1,541 | Citations (PDF) |
| 31 | Allele-Specific CRISPR-Cas9 Genome Editing of the Single-Base P23H Mutation for Rhodopsin-Associated Dominant Retinitis Pigmentosa | 3.5 | 114 | Citations (PDF) |
| 32 | Impact of Genetic Variation on CRISPR-Cas Targeting | 3.5 | 33 | Citations (PDF) |
| 33 | Gene therapy comes of age | 36.2 | 1,269 | Citations (PDF) |
| 34 | Prediction of off-target activities for the end-to-end design of CRISPR guide RNAs | 22.4 | 305 | Citations (PDF) |
| 35 | Response to “Unexpected mutations after CRISPR–Cas9 editing in vivo” | 24.6 | 26 | Citations (PDF) |
| 36 | CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease | 5.5 | 169 | Citations (PDF) |
| 37 | CRISPR-SURF: discovering regulatory elements by deconvolution of CRISPR tiling screen data | 24.6 | 42 | Citations (PDF) |
| 38 | In vivo CRISPR editing with no detectable genome-wide off-target mutations | 37.9 | 303 | Citations (PDF) |
| 39 | Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells | 15.5 | 93 | Citations (PDF) |
| 40 | An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities | 29.8 | 413 | Citations (PDF) |
| 41 | Temporal and Spatial Post-Transcriptional Regulation of Zebrafish
tie1
mRNA by Long Noncoding RNA During Brain Vascular Assembly | 6.0 | 20 | Citations (PDF) |
| 42 | CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR–Cas9 nuclease off-targets | 24.6 | 765 | Citations (PDF) |
| 43 | Genome editing of factor X in zebrafish reveals unexpected tolerance of severe defects in the common pathwayBlood, 2017, 130, 666-676 | 4.2 | 32 | Citations (PDF) |
| 44 | Inducible and multiplex gene regulation using CRISPR–Cpf1-based transcription factors | 24.6 | 200 | Citations (PDF) |
| 45 | Enhanced proofreading governs CRISPR–Cas9 targeting accuracy | 37.9 | 1,115 | Citations (PDF) |
| 46 | Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma | 25.1 | 152 | Citations (PDF) |
| 47 | Defining and improving the genome-wide specificities of CRISPR–Cas9 nucleases | 47.0 | 457 | Citations (PDF) |
| 48 | Open-source guideseq software for analysis of GUIDE-seq data | 29.8 | 71 | Citations (PDF) |
| 49 | Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells | 29.8 | 659 | Citations (PDF) |
| 50 | High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects | 37.9 | 2,517 | Citations (PDF) |
| 51 | Genome Editing in Human Cells Using CRISPR/Cas Nucleases | 0.0 | 12 | Citations (PDF) |
| 52 | Accelerating research through reagent repositories: the genome editing example | 8.1 | 7 | Citations (PDF) |
| 53 | Dimeric CRISPR RNA-Guided FokI-dCas9 Nucleases Directed by Truncated gRNAs for Highly Specific Genome Editing | 3.2 | 133 | Citations (PDF) |
| 54 | Fanconi Anemia Gene Editing by the CRISPR/Cas9 System | 3.2 | 107 | Citations (PDF) |
| 55 | Chromatin regulation at the frontier of synthetic biology | 47.0 | 99 | Citations (PDF) |
| 56 | Standards needed for gene-editing errors | 37.9 | 19 | Citations (PDF) |
| 57 | Engineered CRISPR-Cas9 nucleases with altered PAM specificities | 37.9 | 1,597 | Citations (PDF) |
| 58 | Context influences on TALE–DNA binding revealed by quantitative profiling | 13.7 | 33 | Citations (PDF) |
| 59 | Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model | 3.2 | 17 | Citations (PDF) |
| 60 | Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells | 25.2 | 466 | Citations (PDF) |
| 61 | Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition | 29.8 | 590 | Citations (PDF) |
| 62 | Continuous directed evolution of DNA-binding proteins to improve TALEN specificity | 24.6 | 108 | Citations (PDF) |
| 63 | Hypoxia drives transient site-specific copy gain and drug-resistant gene expression | 4.6 | 82 | Citations (PDF) |
| 64 | A Zebrafish Model of Myelodysplastic Syndrome Produced through tet2 Genomic Editing | 2.5 | 62 | Citations (PDF) |
| 65 | Factor X Mutant Zebrafish Tolerate a Severe Hemostatic Defect in Early Development Yet Develop Lethal Hemorrhage in AdulthoodBlood, 2015, 126, 426-426 | 4.2 | 1 | Citations (PDF) |
| 66 | Correction of theCrb1rd8Allele and Retinal Phenotype in C57BL/6N Mice Via TALEN-Mediated Homology-Directed Repair 2014, 55, 387 | | 66 | Citations (PDF) |
| 67 | Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage | 4.6 | 95 | Citations (PDF) |
| 68 | Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity | 24.6 | 204 | Citations (PDF) |
| 69 | CRISPR-Cas systems for editing, regulating and targeting genomes | 29.8 | 2,951 | Citations (PDF) |
| 70 | Pathways Disrupted in Human ALS Motor Neurons Identified through Genetic Correction of Mutant SOD1 | 16.4 | 444 | Citations (PDF) |
| 71 | Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing | 29.8 | 909 | Citations (PDF) |
| 72 | Improving CRISPR-Cas nuclease specificity using truncated guide RNAs | 29.8 | 1,899 | Citations (PDF) |
| 73 | IκB Kinase β (IKBKB) Mutations in Lymphomas That Constitutively Activate Canonical Nuclear Factor κB (NFκB) Signaling | 2.2 | 24 | Citations (PDF) |
| 74 | Targeted mutagenesis of zebrafish antithrombin III triggers disseminated intravascular coagulation and thrombosis, revealing insight into functionBlood, 2014, 124, 142-150 | 4.2 | 65 | Citations (PDF) |
| 75 | GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases | 29.8 | 2,128 | Citations (PDF) |
| 76 | Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo | 29.8 | 1,369 | Citations (PDF) |
| 77 | Genome and Epigenome Editing: A Revolution in Science and MedicineBlood, 2014, 124, SCI-10-SCI-10 | 4.2 | 0 | Citations (PDF) |
| 78 | CRISPR RNA–guided activation of endogenous human genes | 24.6 | 1,166 | Citations (PDF) |
| 79 | Interactome Maps of Mouse Gene Regulatory Domains Reveal Basic Principles of Transcriptional RegulationCell, 2013, 155, 1507-1520 | 33.7 | 318 | Citations (PDF) |
| 80 | Engineering Customized TALE Nucleases (TALENs) and TALE Transcription Factors by Fast Ligation‐Based Automatable Solid‐Phase High‐Throughput (FLASH) Assembly | 0.0 | 29 | Citations (PDF) |
| 81 | Locus-specific editing of histone modifications at endogenous enhancers | 29.8 | 356 | Citations (PDF) |
| 82 | Efficient genome editing in zebrafish using a CRISPR-Cas system | 29.8 | 2,899 | Citations (PDF) |
| 83 | Translating the Genomics Revolution: The Need for an International Gene Therapy Consortium for Monogenic Diseases | 10.2 | 12 | Citations (PDF) |
| 84 | High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells | 29.8 | 3,110 | Citations (PDF) |
| 85 | piggyBac
transposase tools for genome engineering | 7.5 | 210 | Citations (PDF) |
| 86 | Targeted Deletion and Inversion of Tandemly Arrayed Genes in Arabidopsis thaliana Using Zinc Finger Nucleases | 1.9 | 86 | Citations (PDF) |
| 87 | A Zebrafish Model Of Antithrombin III Deficiency Displays Bleeding and Thrombosis Secondary To Disseminated Intravascular CoagulationBlood, 2013, 122, 200-200 | 4.2 | 1 | Citations (PDF) |
| 88 | A Synthetic Biology Framework for Programming Eukaryotic Transcription Functions | 33.7 | 318 | Citations (PDF) |
| 89 | Engineering Designer Transcription Activator‐‐Like Effector Nucleases (TALENs) by REAL or REAL‐Fast Assembly | 0.0 | 71 | Citations (PDF) |
| 90 | FLASH assembly of TALENs for high-throughput genome editing | 29.8 | 1,174 | Citations (PDF) |
| 91 | TALENs: a widely applicable technology for targeted genome editing | 78.2 | 1,536 | Citations (PDF) |
| 92 | Targeted gene disruption in somatic zebrafish cells using engineered TALENs | 29.8 | 602 | Citations (PDF) |
| 93 | Engineering Designer Nucleases with Customized Cleavage Specificities | 0.0 | 16 | Citations (PDF) |
| 94 | ZFNGenome: A comprehensive resource for locating zinc finger nuclease target sites in model organisms | 3.3 | 50 | Citations (PDF) |
| 95 | Reply to “Genome editing with modularly assembled zinc-finger nucleases” | 24.6 | 72 | Citations (PDF) |
| 96 | Gene Targeting of a Disease-Related Gene in Human Induced Pluripotent Stem and Embryonic Stem Cells | 16.4 | 513 | Citations (PDF) |
| 97 | Zinc-finger Nucleases: The Next Generation Emerges | 10.2 | 324 | Citations (PDF) |
| 98 | Synthetic protein–protein interaction domains created by shuffling Cys
2
His
2
zinc‐fingers | 6.7 | 21 | Citations (PDF) |
| 99 | A Combined Yeast/Bacteria Two-hybrid System | 3.0 | 21 | Citations (PDF) |
| 100 | Repression of phase-variable cup gene expression by H-NS-like proteins in Pseudomonas aeruginosa | 7.5 | 109 | Citations (PDF) |
| 101 | Identifying and modifying protein-DNA and protein-protein interactions using a bacterial two-hybrid selection system | 3.0 | 13 | Citations (PDF) |
| 102 | Activation of prokaryotic transcription through arbitrary protein–protein contacts | 37.9 | 290 | Citations (PDF) |
| 103 | Nodal patterning without Lefty inhibitory feedback is functional but fragile | 1.6 | 62 | Citations (PDF) |
| 104 | Enhancing CRISPR prime editing by reducing misfolded pegRNA interactions | 1.6 | 17 | Citations (PDF) |